Literature DB >> 24474658

CRP gene polymorphism contributes genetic susceptibility to dyslipidemia in Han Chinese population.

Wenbin Wei1, Song Yang, Yingru Qiu, Hairu Wang, Xianghai Zhao, Yanping Zhao, Yun Li, Ming Wu, Yanchun Chen, Wen Wang, Xiaoming Shi, Sijun Liu, Jinfeng Chen, Hongbing Shen, David Zhao, Yanru Su, Chong Shen, Ying-Shui Yao.   

Abstract

C-reactive protein (CRP), an inflammatory marker that statistically predicts future cardiovascular risk, has been reported to be associated with plasma lipid level changes. Whether CRP genetic variants affect lipid metabolism is of importance to investigate. A community-based study population including 2,731 adult subjects aged 18-62 years was used to evaluate the association of CRP gene with dyslipidemia and five tagging SNPs (tagSNPs) were genotyped. Multiple logistic regression was applied to further evaluate relationships between the SNPs and lipid metabolism abnormality and general linear model was applied to compare plasma lipid levels between genotypes. Association analyses indicated that recessive model of SNPs rs876537 and rs4285692 had significant association with elevated HDL after adjustment for covariates. Odds ratio (OR) of rs876537 were 0.60 for HDL > 1.54 versus 1.04-1.54 mmol/L (P = 0.011), as well as, ORs were 0.617 for HDL > 1.83 versus ≤1.35 mmol/L (P = 0.002) and 0.724 for HDL = 1.59-1.83 versus ≤1.35 mmol/L (P = 0.028) respectively. OR of rs4285692 was 0.634 for HDL > 1.83 versus ≤1.35 mmol/L (P = 0.027). Further stratification analysis found significant associations of rs10737175 with elevated HDL (>1.54 vs. 1.04-1.54 mmol/L, OR 0.629 and P = 0.027) and elevated TG (≥1.70 vs. <1.70 mmol/L, ORs of additive and dominant models were 0.628, 0.545 and P values were 0.006, 0.003 respectively) in female. rs4285692 was significantly associated with elevated LDL (≥3.37 vs. <3.37 mmol/L), ORs equaled to 1.532, 2.281 for additive model and recessive model and P values were 0.028, 0.024 respectively in male. Furthermore, quantitative trait analysis indicated the variation T to C of rs876537 significantly affect decreased plasma HDL level (P = 0.014). Our findings suggest that CRP genetic polymorphisms independently had positive association with the risk of HDL, LDL and TG elevating and further replication in other large population and biological function research would be warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24474658     DOI: 10.1007/s11033-014-3087-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

1.  The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Authors:  M S V Elkind; J M Luna; C S Coffey; L A McClure; K M Liu; S Spitalnik; M C Paik; A Roldan; C White; R Hart; O Benavente
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

2.  The relationship between gene polymorphism and CRP level in a Chinese Han population.

Authors:  Ming Yan; Lei Zhao; Fang Zheng; Xiaobo Sun; Ying Zhang; Chunhong Wang
Journal:  Biochem Genet       Date:  2007-02       Impact factor: 1.890

3.  Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke.

Authors:  Heleen M den Hertog; Evita G van den Herik; Diederik W J Dippel; Peter J Koudstaal; Moniek P M de Maat
Journal:  Cerebrovasc Dis       Date:  2010-02-09       Impact factor: 2.762

5.  The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis.

Authors:  Masako Tabuchi; Katsumi Inoue; Hitomi Usui-Kataoka; Kazuko Kobayashi; Misako Teramoto; Koji Takasugi; Kenichi Shikata; Masahiro Yamamura; Kenji Ando; Keiichiro Nishida; Junko Kasahara; Noriaki Kume; Luis R Lopez; Kazuaki Mitsudo; Masakiyo Nobuyoshi; Tatsuji Yasuda; Toru Kita; Hirofumi Makino; Eiji Matsuura
Journal:  J Lipid Res       Date:  2007-01-29       Impact factor: 5.922

6.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Authors:  John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

Review 7.  Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?

Authors:  B G Nordestgaard; J Zacho
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-08-19       Impact factor: 4.222

8.  Relationships among changes in C-reactive protein and cardiovascular disease risk factors with lifestyle interventions.

Authors:  D Young; S Camhi; T Wu; J Hagberg; M Stefanick
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-07-24       Impact factor: 4.222

Review 9.  C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.

Authors:  Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2007-04-30       Impact factor: 24.094

10.  A genome-wide association study identifies protein quantitative trait loci (pQTLs).

Authors:  David Melzer; John R B Perry; Dena Hernandez; Anna-Maria Corsi; Kara Stevens; Ian Rafferty; Fulvio Lauretani; Anna Murray; J Raphael Gibbs; Giuseppe Paolisso; Sajjad Rafiq; Javier Simon-Sanchez; Hana Lango; Sonja Scholz; Michael N Weedon; Sampath Arepalli; Neil Rice; Nicole Washecka; Alison Hurst; Angela Britton; William Henley; Joyce van de Leemput; Rongling Li; Anne B Newman; Greg Tranah; Tamara Harris; Vijay Panicker; Colin Dayan; Amanda Bennett; Mark I McCarthy; Aimo Ruokonen; Marjo-Riitta Jarvelin; Jack Guralnik; Stefania Bandinelli; Timothy M Frayling; Andrew Singleton; Luigi Ferrucci
Journal:  PLoS Genet       Date:  2008-05-09       Impact factor: 5.917

View more
  3 in total

1.  Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder.

Authors:  Hui Hua Chang; Po See Chen; Tzu-Yun Wang; Sheng-Yu Lee; Shiou-Lan Chen; San-Yuan Huang; Jau-Shyong Hong; Yen Kuang Yang; Ru-Band Lu
Journal:  J Affect Disord       Date:  2017-06-09       Impact factor: 4.839

2.  Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population.

Authors:  Semon Wu; Lung-An Hsu; Ming-Sheng Teng; Jeng-Feng Lin; Hsin-Hua Chou; Ming-Cheng Lee; Yi-Ming Wu; Cheng-Wen Su; Yu-Lin Ko
Journal:  Lipids Health Dis       Date:  2016-05-13       Impact factor: 3.876

3.  Roles of C-reactive protein polymorphisms and life event changes on cognitive function in bipolar patients receiving valproate.

Authors:  Po See Chen; Li-Yi Tang; Hui Hua Chang
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.